|
Online Database of Chemicals from Around the World | 产品搜索 | 产品提交 | 产品推广 |
网站主页 >> 化工产品目录 >> 巴非替尼>> 市场分析报告 |
巴非替尼市场分析报告 |
|
Bafetinib Market Research Report 2025 BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS). N-{3-[(5,5'-Bipyrimidin)-2-ylamino]-4-methylphenyl}-4-{[(3S)-3-(dimethylamino)-1-pyrrolidinyl]-methyl}-3-(trifluoromethyl)-benzamide (CAS 887650-05-7) Market Research Report 2025 BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS). Global Market Report of Bafetinib (CAS 887650-05-7) December 2024 Global Market Report of Bafetinib (CAS 887650-05-7) December 2024 CytRx Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... is the (6-Maleimidocaproyl) hydrazone of doxorubicin. Bafetinib: Bafetinib is a drug developed by the Japanese ... has announced plans to develop bafetinib as a treatment for B-cell ... and specific inhibitory properties of bafetinib against Lyn kinase, which ... |